Table 6.
Samples testing positive for antidrug antibodies (ADA)
Subject | Treatment | Sampling time | Assay for ADA against PF-05280014 | Assay for ADA against references | ||
---|---|---|---|---|---|---|
ADA | Titre | ADA | Titre | |||
Subject 1 | PF-05280014 | Pre-dose | Positive | 2.32 | Positive | 2.25 |
Subject 2 | Trastuzumab-EU | 1680 h | Negative | <1.00 | Positive | 2.16 |